Professional
Added to YB: 2025-09-24
Pitch date: 2025-07-24
DERM [neutral]
Journey Medical Corporation
-1.96%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$177.0M
Pitch Price
$7.65
Price Target
20.00 (+194%)
Dividend
N/A
EV/EBITDA
119.72
P/E
-28.15
EV/Sales
2.60
Sector
Pharmaceuticals
Category
growth
Summers Value Partners Portfolio Holding: Journey Medical Corporation
DERM (holding update): Dermatology pharma co led by ex-Medicis team. Emrosi launched Apr 2024 for rosacea, superior to prior standard Oracea in Phase 3 trials, patent to 2039. Early sales $15M+ annualized, targeting $100M in few years. $55M 2024 rev, forecasting $1.50 EPS by 2027. Price target $20.
Read full article (1 min)